Cargando…

Broad-Spectrum Small-Molecule Inhibitors of the SARS-CoV-2 Spike—ACE2 Protein–Protein Interaction from a Chemical Space of Privileged Protein Binders

Therapeutically useful small-molecule inhibitors (SMIs) of protein–protein interactions (PPIs) initiating the cell attachment and entry of viruses could provide novel alternative antivirals that act via mechanisms similar to that of neutralizing antibodies but retain the advantages of small-molecule...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chuang, Sung-Ting, Buchwald, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504289/ https://www.ncbi.nlm.nih.gov/pubmed/36145305 http://dx.doi.org/10.3390/ph15091084

Ejemplares similares

The SARS-CoV-2 Spike protein has a broad tropism for mammalian ACE2 proteins
por: Conceicao, Carina, et al.
Publicado: (2020)

PEPscan: A Broad Spectrum Approach for the Characterization of Protein-Binder Interactions?
por: Rebollo, Angelita, et al.
Publicado: (2022)

A tetrameric ACE2 protein broadly neutralizes SARS-CoV-2 spike variants of concern with elevated potency
por: Leach, Adam, et al.
Publicado: (2021)

Methylene Blue Inhibits the SARS-CoV-2 Spike–ACE2 Protein-Protein Interaction–a Mechanism that can Contribute to its Antiviral Activity Against COVID-19
por: Bojadzic, Damir, et al.
Publicado: (2021)

Binder design for targeting SARS-CoV-2 spike protein: An in silico perspective
por: Etemadi, Ali, et al.
Publicado: (2022)

Lineage-mosaic and mutation-patched spike proteins for broad-spectrum COVID-19 vaccine
por: Wu, Yangtao, et al.
Publicado: (2022)

The inhibitory effect of a coronavirus spike protein fragment with ACE2
por: Peter, Emanuel K., et al.
Publicado: (2021)

Glycosite-deleted mRNA of SARS-CoV-2 spike protein as a broad-spectrum vaccine
por: Wu, Chung-Yi, et al.
Publicado: (2022)

Modeling SARS-CoV-2 spike/ACE2 protein–protein interactions for predicting the binding affinity of new spike variants for ACE2, and novel ACE2 structurally related human protein targets, for COVID-19 handling in the 3PM context
por: Tragni, Vincenzo, et al.
Publicado: (2022)

Biomechanical characterization of SARS-CoV-2 spike RBD and human ACE2 protein-protein interaction
por: Cao, Wenpeng, et al.
Publicado: (2021)

Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2
por: Chan, Kui K., et al.
Publicado: (2020)

The sequence of human ACE2 is suboptimal for binding the S spike protein of SARS coronavirus 2
por: Procko, Erik
Publicado: (2020)

Revealing the Mechanism of SARS-CoV-2 Spike Protein Binding With ACE2
Publicado: (2020)

Biophysical properties of the isolated spike protein binding helix of human ACE2
por: Das, Anirban, et al.
Publicado: (2021)

Variations in cell-surface ACE2 levels alter direct binding of SARS-CoV-2 Spike protein and viral infectivity: Implications for measuring Spike protein interactions with animal ACE2 orthologs
por: Kazemi, Soheila, et al.
Publicado: (2021)

Variations in Cell Surface ACE2 Levels Alter Direct Binding of SARS-CoV-2 Spike Protein and Viral Infectivity: Implications for Measuring Spike Protein Interactions with Animal ACE2 Orthologs
por: Kazemi, Soheila, et al.
Publicado: (2022)

Ceftazidime exhibits a broad inhibition to the infection of SARS-CoV-2 prototype and Omicron variant in vitro by blocking spike protein-ACE2 interaction
por: Zheng, Yun-zhe, et al.
Publicado: (2023)

De Novo Discovery of High-Affinity Peptide Binders for the SARS-CoV-2 Spike Protein
por: Pomplun, Sebastian, et al.
Publicado: (2020)

Chloroquine and Hydroxychloroquine Interact Differently with ACE2 Domains Reported to Bind with the Coronavirus Spike Protein: Mediation by ACE2 Polymorphism
por: Badraoui, Riadh, et al.
Publicado: (2021)

Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection
por: Luan, Junwen, et al.
Publicado: (2020)

Perturbation of ACE2 Structural Ensembles by SARS-CoV-2 Spike Protein Binding
por: Uyar, Arzu, et al.
Publicado: (2021)

Modelling SARS-CoV-2 spike-protein mutation effects on ACE2 binding
por: Thakur, Shivani, et al.
Publicado: (2023)

Cellular protein GLTSCR2: A valuable target for the development of broad-spectrum antivirals
por: Li, Cui-Cui, et al.
Publicado: (2017)

SARS-CoV-2 Spike Protein Interaction Space
por: Lungu, Claudiu N., et al.
Publicado: (2023)

De novo design of protein peptides to block association of the SARS-CoV-2 spike protein with human ACE2
por: Huang, Xiaoqiang, et al.
Publicado: (2020)

Lenalidomide downregulates ACE2 protein abundance to alleviate infection by SARS-CoV-2 spike protein conditioned pseudoviruses
por: Su, Siyuan, et al.
Publicado: (2021)

E-Volve: understanding the impact of mutations in SARS-CoV-2 variants spike protein on antibodies and ACE2 affinity through patterns of chemical interactions at protein interfaces
por: Dos Santos, Vitor Pimentel, et al.
Publicado: (2022)

Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein
por: Calcagnile, Matteo, et al.
Publicado: (2021)

ACE2-targeting monoclonal antibody as potent and broad-spectrum coronavirus blocker
por: Chen, Yuning, et al.
Publicado: (2021)

Native Structure-Based Peptides as Potential Protein–Protein Interaction Inhibitors of SARS-CoV-2 Spike Protein and Human ACE2 Receptor
por: Odolczyk, Norbert, et al.
Publicado: (2021)

Improvement of native structure-based peptides as efficient inhibitors of protein-protein interactions of SARS-CoV-2 spike protein and human ACE2
por: Odolczyk, Norbert, et al.
Publicado: (2022)

Discovery of human ACE2 variants with altered recognition by the SARS-CoV-2 spike protein
por: Heinzelman, Pete, et al.
Publicado: (2020)

Involvement of Spike Protein, Furin, and ACE2 in SARS-CoV-2-Related Cardiovascular Complications
por: Ming, Yi, et al.
Publicado: (2020)

Structural basis for the different states of the spike protein of SARS-CoV-2 in complex with ACE2
por: Yan, Renhong, et al.
Publicado: (2021)

ACE2-cytomimetic particles restrict SARS-Cov-2 spike protein binding to cellular targets
por: Strong, Thomas A., et al.
Publicado: (2021)

Endothelial glycocalyx shields the interaction of SARS-CoV-2 spike protein with ACE2 receptors
por: Targosz-Korecka, Marta, et al.
Publicado: (2021)

Molecular modeling of the interaction of ligands with ACE2–SARS-CoV-2 spike protein complex
por: Isaac-Lam, Meden F.
Publicado: (2021)

Discovery of human ACE2 variants with altered recognition by the SARS-CoV-2 spike protein
por: Heinzelman, Pete, et al.
Publicado: (2021)

Privileged Structures and Polypharmacology within and between Protein Families
por: Meyers, Joshua, et al.
Publicado: (2018)

Learning protein binding affinity using privileged information
por: Abbasi, Wajid Arshad, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_cco5csu0i3m8bds4qjso7censi